PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Mometasone furoate - Allergic rhinitis
PAD Profile : Mometasone furoate - Allergic rhinitis
Keywords :
Hay fever, hayfever, antihistamines, nasal sprays, allergy, seasonal allergic rhinitis, pollen allergy, intranasal corticosteroids, INCS
Brand Names Include :
Nasonex
Traffic Light Status
Status 1 of 1.
Status :
Green (see narrative)
Important
Formulations :
- Nasal spray
Important Information :
Beclometasone (200 dose container) is the preferred intranasal steroid for allergic rhinitis. Mometasone is 2nd line, once daily.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Fluticasone furoate
- Cetirizine hydrochloride
- Loratadine
- Triamcinolone acetonide
- Beclometasone dipropionate
- Azelastine hydrochloride
- Desloratadine
- Levocetirizine
- Budesonide
- Ipratropium bromide
- Bilastine
- Mizolastine
- Acrivastine
- Fexofenadine hydrochloride
- Rupatadine fumarate
- House dust mites allergen extract
- White Birch pollen allergen extract
- Mometasone furoate/olopatadine hydrochloride
- Chlorphenamine maleate
- Ketotifen fumarate
- Promethazine hydrochloride
- Fluticasone propionate (Nasal)
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
05 April 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
Generic mometasone furoate (once daily) nasal spray was agreed as a 1st line treatment option for intranasal corticosteroids.
Generic beclometasone or Beconase nasal spray (200 dose container) is an appropriate 1st line alternative.
Consider mometasone if an intranasal corticosteroid is required for short term use due to systemic absorption (6-18years).
Associated BNF Codes
12. Ear, Nose and Oropharynx
12.02.01. Drugs used in nasal allergy